I am a clinical microbiologist with expertise in molecular diagnosis of infectious diseases. As Chief of the Clinical Microbiology Laboratory, I am responsible for the management and oversight of specimen testing in the laboratory and provide clinical consultation regarding the ordering of diagnostic tests and interpretation of their results. My research interests include the development, validation, and clinical evaluation of molecular tests that offer faster and more-sensitive diagnosis of infectious diseases with the goal of improving patient care.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Visit PubMed for a full listing of Dr. Babady’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Esther Babady discloses the following relationships and financial interests:
Arc Bio, LLC Provision of Services (uncompensated)
Karius, Inc. Provision of Services
Roche Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at firstname.lastname@example.org.